| Hans-Günter Meyer-Thompson | Naltrexon
Secondary analysis of a combined harm-reduction treatment and extended-release naltrexone randomized clinical trial for alcohol use disorder: Differences across race, ethnicity and sex assigned at birth.
Secondary analysis of a combined harm-reduction treatment and extended-release naltrexone randomized clinical trial for alcohol use disorder: Differences across race, ethnicity and sex assigned at birth.
Goldstein SC, Weiss NH, Yang M, Feldstein Ewing SW, Collins SE.
Addiction. 2026;121(4):790–803. doi.org/10.1111/add.70251